A three-decade experience of radical open endvenectomy with pericardial patch graft for correction of Budd-Chiari syndrome

Ichikawa, Hitoshi; Morishima, Yuji; Nagano, Takaaki; Arakaki, Katsuya; Yamashiro, Satoshi; Kuniyoshi, Yukio

doi:10.1016/j.jvs.2009.03.040

Cited by 19 publications

(4 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Surgical management involves membrane resection, IVC reconstruction, portosystemic shunts, portoarterial shunts and liver transplantation (14)(15)(16)(17)(18) Endovascular management includes balloon angioplasty, stunt placement, catheter directed thrombolysis and Trans jugular intrahepatic portosystemic shunt. Our patient was managed with IVCangioplasty with stenting & was done.…”

Section: Discussionmentioning

confidence: 99%

Budd Chiari Syndrome- A Rare Case Report

Sudhish¹

2019

jmscr

View full text Add to dashboard Cite

The Budd-Chiari syndrome (BCS) is a rare life threatening and clinically challenging disorder defined by obstruction of hepatic venous outflow anywhere from the small hepatic veins to the suprahepatic inferior vena cava. It is considered as a manifestation of underlying prothrombotic risk factors of which myeloproliferative disorders are the most common ones. We describe a 41year old Male who presented with bilateral lower limb edema and abdominal distension with visible veins over the anterior abdomen which on further evaluation was diagnosed as Budd-chiari syndrome. Budd Chiari syndrome requires a prompt and accurate diagnosis with an aggressive treatment which depends on the cause, clinical presentation and anatomical location of the problem.

show abstract

Section: Discussionmentioning

confidence: 99%

Budd Chiari Syndrome- A Rare Case Report

Sudhish¹

2019

jmscr

View full text Add to dashboard Cite

show abstract

“…[207][208][209][210][211] In cases with liver failure, liver transplantation should be considered. 90,124,204,[212][213][214][215][216][217][218][219]…”

Section: Guidelines For Treatment Of Splenomegaly and Hypersplenismmentioning

confidence: 99%

“…In acute cases with thrombus obstruction up to the peripheral part of the hepatic vein, the liver resection and peripheral hepatic vein–right atrium anastomosis may be an option . In cases with liver failure, liver transplantation should be considered …”

Section: Guidelines For Treatment Of Aberrant Portal Hemodynamicsmentioning

confidence: 99%

Diagnosis and treatment guidelines for aberrant portal hemodynamics

Furuichi

Tanaka

Takikawa

et al. 2017

Hepatology Research

View full text Add to dashboard Cite

Idiopathic portal hypertension (IPH), causing aberrant portal hemodynamics, is a disease with an as yet unidentified cause and no established treatment protocol. The Japanese research group on IPH in Japan was set up in 1975 by the Ministry of Health, Labor and Welfare. Extrahepatic portal obstruction and Budd-Chiari syndrome (BCS) have since been added to the group's research subjects. The aims of the research group are to accurately evaluate the current status of the three diseases in Japan, elucidate their etiology and pathogenesis, and develop new treatments. Due to the long-term efforts of the Japanese research group, aberrant portal hemodynamics has been investigated in a variety of aspects, from epidemiological and pathological studies to molecular biology analyses. As a result, it has been shown that there are abnormal genes in the liver, specific for IPH. In addition, pathological findings of BCS were internationally compared and the difference in findings between Japan and Europe (or North America) has been clarified. Furthermore, it was found that complication rates of hepatocellular carcinoma in BCS were higher in Japan. Based on the research, "Diagnosis and treatment of aberrant portal hemodynamics (2001)", including diagnostic criteria for aberrant portal hemodynamics, was published in 2001. In 2013, it was revised to "Diagnosis and treatment guidelines for aberrant portal hemodynamics (2013)" after the incorporation of diagnosis and treatment in accordance with its current status.

show abstract

“…The results of IVC thrombectomy and IVC plasty using a patch graft carried out in Japan reported that the 5‐ and 10‐year patency rates without reoperation or percutaneous transvenous balloon venoplasty for reconstructed IVCs were 90% and 84%, respectively, while the 5‐ and 10‐year survival rates were 89% and 70%, respectively …”

Section: Treatmentmentioning

confidence: 99%

Budd–Chiari syndrome: Focus on surgical treatment

Hidaka

Eguchi

2016

Hepatology Research

View full text Add to dashboard Cite

Budd-Chiari syndrome (BCS) is caused by an obstruction in the hepatic venous outflow tract at various levels from small hepatic veins to the inferior vena cava (IVC) due to thrombosis or fibrous sequelae. This rare disease mainly affects young adults. Risk factors have been identified and patients often have multiple risk factors. Myeloproliferative diseases of atypical presentation account for nearly 50% of patients in Europe and North America countries. Multistep management is required for such patients. Interventional revascularization and transjugular intrahepatic portosystemic shunt procedure are indicated after initial anticoagulation therapy, whereas IVC plasty using a patch graft is indicated for obstruction of the IVC. Liver transplantation (LT) is usually indicated as a treatment for liver failure despite various treatments. The outcomes of LT are good, with a 5-year survival after LT of nearly 70%.

show abstract

A three-decade experience of radical open endvenectomy with pericardial patch graft for correction of Budd-Chiari syndrome

Abstract: The autologous pericardium patch is effective and durable for reconstructing a diseased IVC in BCS.

Cited by 19 publications

References 22 publications

Budd Chiari Syndrome- A Rare Case Report

Budd Chiari Syndrome- A Rare Case Report

Diagnosis and treatment guidelines for aberrant portal hemodynamics

Budd–Chiari syndrome: Focus on surgical treatment

Contact Info

Product

Resources

About